Lazard Growth Acquisition Corp I (LGAC) 10-K30 Mar 222021 FY Annual reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2021	Mar. 01, 2022	Jun. 30, 2021
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Registrant Name	LAZARD GROWTH ACQUISITION CORP. I
Entity Central Index Key	0001836337
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Shell Company	true
Entity File Number	001-40035
Entity Incorporation State Country Code	E9
Entity Tax Identification Number	98-1571783
Entity Address Address Line1	30 Rockefeller Plaza
Entity Address City Or Town	New York
Entity Address State Or Province	NY
Entity Address Postal Zip Code	10112
City Area Code	212
Local Phone Number	632-6000
Document Annual Report	true
Document Transition Report	false
ICFR Auditor Attestation Flag	false
Entity Public Float			$ 562,350,000
Auditor Firm ID	688
Auditor Name	Marcum LLP
Auditor Location	New York, New York USA
Documents Incorporated by Reference	Documents Incorporated by Reference: None.
Units, Each Consisting of One Class A Ordinary Share and One-fifth of One Redeemable Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
Trading Symbol	LGACU
Security Exchange Name	NASDAQ
Class A Ordinary Shares, Par Value $0.0001 Per Share
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	LGAC
Security Exchange Name	NASDAQ
Redeemable Warrants, Exercisable for One Class A Ordinary Share at Exercise Price of $11.50 Per Share
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol	LGACW
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		57,500,000
Class B Ordinary Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		14,375,000

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 660,069	$ 25,000
Prepaid expenses	1,056,726
Total current assets	1,716,795	25,000
Other assets:
Cash equivalents held in Trust Account	575,033,252	0
Deferred offering costs		629,750
TOTAL ASSETS	576,750,047	654,750
Current liabilities:
Related party loans	2,000,000	0
Promissory note payable		86,750
Accrued expenses and payable to affiliate	3,997,673
Accrued offering and formation costs	70,000	550,000
Total current liabilities	6,067,673	636,750
Other liabilities:
Deferred underwriting commissions	20,125,000
Total liabilities	44,207,673	636,750
Commitments and contingencies
Shareholders' Equity (Deficit)
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid in capital		23,562
Accumulated deficit	(42,459,064)	(7,000)
Total shareholders' equity (deficit)	(42,457,626)	18,000
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)	576,750,047	654,750
Class A Ordinary Shares
Other liabilities:
Warrants exercisable for Class A ordinary shares, at fair value	18,015,000
Class A Ordinary Shares Subject to Possible Redemption
Temporary Equity
Class A ordinary shares subject to possible redemption; 57,500,000 and 0 shares authorized, issued and outstanding, respectively, at $10.00 per share	575,000,000
Class B Ordinary Shares
Shareholders' Equity (Deficit)
Ordinary shares	$ 1,438	$ 1,438

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Preference shares, par value	$ 0.0001	$ 0.0001
Preference shares, shares authorized	5,000,000	5,000,000
Preference shares, shares issued	0	0
Preference shares, shares outstanding	0	0
Class A Ordinary Shares Subject to Possible Redemption
Temporary equity, shares authorized	57,500,000	0
Temporary equity, shares issued	57,500,000	0
Temporary equity, shares outstanding	57,500,000	0
Temporary equity, redemption per share	$ 10	$ 10
Class B Ordinary Shares
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	14,375,000	14,375,000
Common stock, shares outstanding	14,375,000	14,375,000

Statement of Operations

Statement of Operations - USD ($)		1 Months Ended	12 Months Ended
Statement of Operations - USD ($)		Dec. 31, 2020	Dec. 31, 2021
EXPENSES
General and administrative expenses			$ 5,516,891
Formation costs		$ 7,000
Total expenses		7,000	5,516,891
OTHER INCOME (EXPENSE)
Expensed offering costs			(714,494)
Change in fair value of warrant liability			4,535,000
Interest on trust account			33,252
Total other income (expenses)			3,853,758
NET LOSS		$ (7,000)	(1,663,133)
Class A Ordinary Shares
OTHER INCOME (EXPENSE)
Change in fair value of warrant liability			$ 4,535,000
Weighted average number of shares outstanding			50,883,562
Basic and diluted net income per share	[1]		$ (0.03)
Non-redeemable Ordinary Shares
OTHER INCOME (EXPENSE)
Weighted average number of shares outstanding		12,500,000	14,375,000
Basic and diluted net income per share			$ (0.03)

[1]	The period from December 10, 2020 (Inception) through December 31, 2020 excludes an aggregate of 1,875,000 Class B ordinary shares representing the maximum number of shares subject to forfeiture if the over-allotment option had not been exercised in full by the underwriter (see Note 5).

Statement of Operations (Parent

Statement of Operations (Parenthetical) - Over-Allotment Option - shares	Feb. 10, 2021	Dec. 31, 2020	Dec. 31, 2021
Ordinary shares subject to forfeiture	7,500,000
Class B Ordinary Shares
Ordinary shares subject to forfeiture	1,875,000	1,875,000	1,875,000

Statement of Changes in Shareho

Statement of Changes in Shareholders' Equity (Deficit) - USD ($)		Total	Class A Ordinary Shares	Class B Ordinary Shares	Common StockClass A Ordinary Shares	Common StockClass B Ordinary Shares	Accumulated Deficit	Additional Paid in Capital
Beginning Balance at Dec. 09, 2020
Issuance of ordinary shares	[1]	25,000				$ 1,438		$ 23,562
Issuance of ordinary shares, shares	[1]					14,375,000
Net Loss		(7,000)					$ (7,000)
Ending Balance at Dec. 31, 2020		18,000				$ 1,438	(7,000)	23,562
Ending Balance, shares at Dec. 31, 2020			0	14,375,000		14,375,000
Issuance of ordinary shares		530,587,507			$ 5,750			530,581,757
Issuance of ordinary shares, shares					57,500,000
Proceeds of sale of Private Placement Warrants in excess of fair value		3,600,000						3,600,000
Class A ordinary shares subject to possible redemption		(575,000,000)			$ (5,750)		(40,788,931)	$ (534,205,319)
Class A ordinary shares subject to possible redemption, shares					(57,500,000)
Net Loss		(1,663,133)					(1,663,133)
Ending Balance at Dec. 31, 2021		$ (42,457,626)				$ 1,438	$ (42,459,064)
Ending Balance, shares at Dec. 31, 2021			57,500,000	14,375,000		14,375,000

[1]	The period from December 10, 2020 (Inception) through December 31, 2020 includes an aggregate of 1,875,000 Class B ordinary shares, representing the maximum number of shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5).

Statement of Changes in Share_2

Statement of Changes in Shareholders' Equity (Deficit) (Parenthetical) - Over-Allotment Option - shares	Feb. 10, 2021	Dec. 31, 2020	Dec. 31, 2021
Ordinary shares subject to forfeiture	7,500,000
Class B Ordinary Shares
Ordinary shares subject to forfeiture	1,875,000	1,875,000	1,875,000

Statements of Cash Flow

Statements of Cash Flow - USD ($)	1 Months Ended	12 Months Ended
Statements of Cash Flow - USD ($)	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net Loss	$ (7,000)	$ (1,663,133)
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liability		(4,535,000)
Expensed offering costs		714,494
Interest on trust account		(33,252)
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:
Prepaid expenses		(1,056,726)
Accrued expenses and payable to affiliates		3,997,673
Accrued offering and formation costs	7,000	(7,000)
Net Cash used in operating activities		(2,582,944)
Investing Activities:
Cash placed in trust		(575,000,000)
Cash used in investing activities		(575,000,000)
Financing Activities:
Proceeds from sale of Initial Public Offering Units		575,000,000
Proceeds from sale of Private Placement Warrants		13,500,000
Payment of underwriting discount		(11,500,000)
Payment of offering costs		(695,238)
Proceeds from promissory note payable		100,833
Payment of promissory note payable		(187,582)
Proceeds from related party loans		2,000,000
Net cash provided by financing activities	25,000	578,218,013
Net Change in Cash	25,000	635,069
Cash - Beginning of period		25,000
Cash - End of period	25,000	660,069
Non-cash investing and financing activities:
Deferred offering costs included in accrued offering and formation costs	629,750	70,000
Deferred underwriting commission		$ 20,125,000
Class B Ordinary Shares
Financing Activities:
Proceeds from issuance of Class B ordinary shares	$ 25,000

Organization and Plan of Busine

Organization and Plan of Business Operations	12 Months Ended
Organization and Plan of Business Operations	Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Plan of Business Operations	Note 1 - Organization and Plan of Business Operations Lazard Growth Acquisition Corp. I “Company”) check company, incorporated Cayman , The was for the effecting combination one Combination”). All activity through December 31 2021 relates Company’s formation initial public offering (“Initial Public Offering”), which described below, and after the Initial Public Offering, identifying and evaluating target companies for a Business Combination. Company will generate any operating revenues until after the completion Business Combination, the earliest. The Company w ill generate non-operating income form interest income from proceeds derived from the Initial Public Offering. Company selected December fiscal year end. The registration statement for the Initial Public Offering became effective on February 9, 2021. On February 12, 2021, the Company consummated the Initial Public Offering of 57,500,000 units (the “Units”), including 7,500,000 Units sold upon exercise in full of the underwriter’s over-allotment option, at $10.00 per Unit, which is discussed in of 9,000,000 to closing of the . The Company’s management broad discretion with respect specific application net proceeds Initial Public Offering sale Private Placement Warrants, although substantially net proceeds intended applied generally toward consummating Business Combination. stock exchange listing rules require that Business Combination must with or more operating businesses assets with fair market value equal least assets held the Trust Account defined below) (excluding amount deferred underwriting commissions taxes payable income earned Trust Account). Company will only complete Business Combination post-Business Combination company owns acquires more issued and outstanding voting securities the target otherwise acquires controlling interest the target business sufficient required register investment company under Investment Company Act 1940, (the Act”). will able t successfully effect Business Combination. Upon closing Initial Public Offering , management agreed that $10.00 Unit sold Initial Public Offering, including proceeds the sale Private Placement , were placed trust account (“Trust Account”) invested U.S. government securities forth 2(a)(16) Investment with maturity days less, open-ended investment company that holds itself money fund solely U.S. under 2a-7 the Business Combination (ii) distribution funds Trust Account Company’s shareholders, described below. The Company will provide holders public shares (the “Public Shareholders”) with opportunity redeem portion public shares upon (i) connection with general meeting called approve Business Combination (ii) means tender offer. decision whether will seek shareholder or be entitled redeem their Public Shares, equal aggregate amount then deposit Trust Account, calculated business days prior consummation Business Combination (initially payable), divided the number then issued and outstanding public shares, subject certain limitations. The per-share amount distributed the Public Shareholders properly redeem their shares will reduced deferred underwriting will underwriter (as discussed in Note 8 ). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares were classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with Business Combination only Company tangible assets at $5,000,001 seeks shareholder receives ordinary resolution under of shareholders who attend vote general meeting Company. shareholder vote not required and the Company does not decide hold shareholder vote for business other legal reasons, Company will, pursuant Amended Restated Memorandum Articles Association, conduct redemptions pursuant offer rules Securities (“SEC”), and file tender offer documents containing substantially same information would included proxy statement with prior completing seeks shareholder approval connection with Business Combination, the Sponsor and each of our executive officers and directors have agreed vote its Founder Shares (as defined Note Public Shares purchased during after Initial Public Offering favor of Public Shares, without voting, they vote, irrespective whether they vote for against proposed Business Combination. Notwithstanding the foregoing, the of the Combination and the redemptions pursuant the offer rules, Public Shareholder, any any The Sponsor and each of our executive officers and directors have agreed to waive their redemption rights with respect to any Founder Shares and Public Shares held by it in connection with (i) the completion of a Business Combination and (ii) a shareholder vote to approve an amendment to the Amended and Restated Memorandum and Articles of Association that (A) modify the substance or timing of the Company’s obligation to allow redemption of Class A ordinary shares in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights. Additionally, the Sponsor and each of our executive officers and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to consummate a Business Combination within the Combination Period. The Company has until 24 months from the closing of the Initial Public Offering to consummate a Business Combination (or such extended time beyond 24 months, as a result of a shareholder vote to amend its Amended and Restated Memorandum and Articles of Association) (the “Combination Period”). However, if the Company has not completed a Business Combination within Combination Period, Company will cease the purpose of winding promptly reasonably possible ten business thereafter, cash, equal the aggregate amount on deposit in Trust Account, including interest earned previously pay its any (less up to $100,000 of interest to pay dissolution expenses) divided the and extinguish the the the liquidating and the approval Company’s Board liquidate dissolve, the law for of creditors applicable law. There will The Sponsor and each of our executive officers and directors have agreed waive rights liquidating distributions from Trust Account with respect the Period. However, Sponsor each of our executive officers and directors Public Shares, such Public Shares will distributions from Account fails to within Period. underwriter waive their rights their deferred underwriting commissions (see Note 8 held Trust Account event the Company does complete Business Combination within Combination Period, such event, such amounts will included with other funds held Trust Account that will available fund redemption Public Shares. event such distribution, possible that per share value remaining distribution will Initial Public Offering price Unit ($10.00). In order protect the amounts held the Trust Account, the Sponsor agreed that will liable the Company and the extent any claims third party (other than the Company’s independent public accounting firm) for services rendered products sold the Company, prospective target business with which the Company has discussed entering into transaction agreement, reduce the amount funds Trust Account below lesser (i) $10.00 per Public Share (ii) actual amount per Public Share held the Trust Account the date the liquidation the Trust Account, less than $10.00 per Public Share, due reductions the value trust assets, each case net the interest that withdrawn taxes. This liability will apply claims third party or prospective target business executed waiver of any and all rights seek access the Trust Account and any claims under the Company’s indemnity underwriter Initial Public Offering against certain liabilities, including liabilities under the Securities Act 1933, amended (the “Securities Act”). the event that executed waiver is deemed unenforceable against third party, the Sponsor will not responsible the extent any liability such third-party claims. Company will seek reduce possibility that Sponsor will have indemnify the Trust Account due claims of creditors by endeavoring have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving right, title, interest claim kind monies held Trust Account. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 global pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for and evaluation of a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Going Concern Consideration On March 26, 2021, the Sponsor committed $1,300,000 to be provided to the Company to fund working capital requirements prior to an initial Business Combination. On August 5, 2021, the Sponsor amended its working capital loan to provide additional borrowings up to a total amount of $2,000,000. On March 30, 2022, the Sponsor further amended the working capital loan to provide additional borrowing up to a total borrowing of $5,000,000. After borrowing $2,000,000, the Company had cash of $660,069 as of December 31, 2021, and the Company does not have sufficient liquidity to meet its anticipated obligations during the period beginning with the date of issuance of these financial statements through February 12, 2023, the date the Company will cease all operations and begin liquidation if it has not completed a Business Combination (or any extended time that the Company has to consummate a Business Combination beyond February 12, 2023 as a result of a shareholder vote to amend the Amended and Restated Memorandum and Articles Association). the Sponsor or an affiliate of the Sponsor may, but is not obligated to, loan the Company additional funds may needed by the Company, t

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Dec. 31, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 - Significant Accounting Policies Basis of Presentation The accompanying financial statements have been prepared accordance with accounting principles generally accepted United States America (“GAAP”) pursuant rules regulations of Emerging Growth Company The Company “emerging growth company,” defined Section 2(a) Securities Act, modified the Jumpstart Our Business Startups Act 2012 (the “JOBS Act”), and may take advantage certain exemptions from various reporting requirements that are applicable other public companies that are not emerging growth companies including, but not limited to, not being required comply with the auditor attestation requirements Section 404 the Sarbanes-Oxley Act 2002, reduced disclosure obligations regarding executive compensation its periodic reports and proxy statements, and exemptions Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies to comply with new revised financial accounting standards until private companies (that those that have not had Securities Act registration statement declared effective not have class securities registered under Exchange Act) required comply with revised financial accounting standards. The JOBS Act provides that company can elect opt out the extended transition period and comply with requirements that apply non-emerging growth companies but such election opt out irrevocable. Company elected not opt out such extended transition period which means that when standard issued revised different application dates public private companies, Company, emerging growth company, adopt revised standard time private companies adopt revised standard. This make comparison Company’s financial statements with another public company which neither emerging growth company emerging growth company which has opted out using extended transition period difficult impossible because the potential differences accounting standards used. Use of Estimates The preparation financial statements conformity with GAAP requires management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Estimates, by their nature, are based o Cash and Cash Equivalents Held in Trust Account Cash and cash equivalents include cash on hand and on deposit at banking institutions as well as all highly liquid short-term investments with original maturities of ninety (90) days or less. The Company held cash of $660,069 and $25,000 in a demand deposit account as of December 31, 2021 and December 31, 2020, respectively. The Company held $575,033,252 and $0 as of December 31, 2021 and December 31, 2020, respectively, in the Trust Account that are characterized as Level I investments within the fair value hierarchy under ASC 820. The cash equivalents held in the Trust Account are held in money market funds and are considered restricted. Deferred Offering Costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. These costs, together with the upfront underwriting discounts, the deferred underwriting commissions and the financial advisory fee in connection with the Initial Public Offering were allocated between the Public Shares and Public Warrants and charged to shareholder’s equity and operating expenses, respectively, upon the completion of the Initial Public Offering. Warrants Exercisable for Class A Ordinary Shares The Company accounts for the warrants issued in connection with the Initial Public Offering in accordance with ASC 480-10, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity,” which provides that the Company classifies the warrant instruments as a liability at its fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, in accordance with ASC Topic 815, and any change in fair value is recognized in the Company’s statement of operations. Income Taxes The Company accounts for income taxes under ASC 740, "Income Taxes" ("ASC 740"). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC Topic prescribes recognition threshold measurement attribute financial statement recognition measurement positions taken expected taken return. those benefits recognized, position must more likely than sustained upon examination taxing tax jurisdiction. Company recognizes accrued interest penalties related unrecognized benefits as amounts accrued interest penalties. Company currently aware issues under review that could result significant payments, deviation from position. The Company considered exempted Cayman Islands company with connection other the Cayman Islands United States. such, Company’s provision zero periods presented. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Net Loss Per Ordinary Share Net loss per share is computed by dividing by weighted average number of ordinary shares outstanding during period, excluding ordinary shares subject to forfeiture As of December 31, 2020, the Company had 1,875,000 were to extent shares were excluded from the calculation of the basic and diluted w eighted average number of non-redeemable Class B shares outstanding and basic and diluted net loss per share of non-redee mable Class B ordinary shares. At December 31 , 2021 and 2020, the Company did no t have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the losses of the Company. As a result, diluted loss per share is the same as basic loss per share for the period s presented. Concentration of Credit Risk Financial instruments that $250,000. The Company not experienced losses this account and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value Company’s assets liabilities, which qualify financial instruments under ASC 820, “Fair Value Measurement,” approximates carrying amounts represented accompanying balance sheet, primarily due their short-term nature. Recent Accounting Standards In August 2020, the Financial Accounting Standards Board issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for small reporting companies beginning January 1, 2024 and should be applied on a full or modified retrospective basis. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Initial Public Offering

Initial Public Offering	12 Months Ended
Initial Public Offering	Dec. 31, 2021
Equity [Abstract]
Initial Public Offering	Note 3 - Initial Public Offering On February 12, 2021, pursuant to the Initial Public Offering, the Company sold 57,500,000 Units, including 7,500,000 Units sold upon exercise in full of the underwriter’s over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-fifth of one redeemable warrant share Transaction costs amounted to $32,476,988, consisting of $11,500,000 of underwriting fees (that includes a $3,000,000 financial advisory fee paid to Lazard Frères & Co. LLC for which the Company was reimbursed by the underwriter), $20,125,000 of deferred underwriting fees and $851,988 of other offering costs.

Private Placement

Private Placement	12 Months Ended
Private Placement	Dec. 31, 2021
Equity [Abstract]
Private Placement	Note 4 - Private Placement Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased aggregate 9,000,000 $1.50 . Each Private Placement Warrant exercisable purchase one Class ordinary share price $11.50 per share, subject adjustment (see Note 9). portion the proceeds from the Private Placement Warrants were added the proceeds from the Initial Public Offering held the Trust Account. the Company does not complete Business Combination within Combination Period, proceeds from sale Private Placement Warrants will used fund the redemption the Public Shares (subject the requirements applicable law) and the Private Placement The proceeds from the sale of the Private Placement Warrants of $13,500,000 exceeded their estimated fair value of $9,900,000 at the closing of the private placement by $3,600,000, which was recorded in additional paid in capital.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 - Related Party Transactions Founder Shares On December 17 2020, Sponsor paid $25,000 purchase an aggregate of Class ordinary shares (the “Founder Shares”). The Sponsor agreed forfeit Founder Shares the extent which the underwriter exercised its over-allotment option, that the number of On February 5, 2021, the Sponsor transferred 25,000 of its Founder Shares to each of the Company’s five independent directors (125,000 Founder Shares in the aggregate). Effective May 11, 2021, a member of the Company’s board of directors (the “Board”) resigned his position as a member of the Board and subsequently transferred back to the Sponsor the 25,000 Founder Shares he previously received from the Sponsor in connection with his service on the Board. The Sponsor’s transfer of 100,000 Founders Shares to the Company’s directors is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 100,000 shares transferred to the Company’s directors was $342,000 or $3.42 per share. The Founders Shares were effectively transferred subject to a performance condition (i.e., the consummation of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date a Business Combination is considered probable in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) As of December 31, 2021, the Company has not yet entered into any definitive agreements in connection with any Business Combination. Any such agreements may be subject to certain conditions to closing, such as, for example, approval by the Company’s shareholders. As a result, the Company determined that the consummation of a Business Combination is not yet considered probable, and, therefore, no stock-based compensation expense has been recognized. Further, on February 5, 2021, the Sponsor converted into a series limited liability company and LGA HoldCo LLC, an affiliate of Lazard Ltd, provided each of the Company’s executive officers and certain other employees of Lazard Ltd and its subsidiaries the opportunity to purchase certain membership interests in a series of the Sponsor (the “Employee Participation Interests”) pursuant to which such persons have economic interests in certain of the Founder Shares but do not have voting rights or dispositive power with respect thereto. In particular, the Company’s executive officers and such other employees of Lazard Ltd and its subsidiaries possess Employee Participation Interests representing economic interests in approximately 30% in the aggregate of the Company’s issued and outstanding Founder Shares, including approximately 2% in the aggregate which has been provided by the Company’s executive officers; however, the Sponsor maintains the voting rights attributable to, and the dispositive power in respect of, all such Founder Shares. Each of the Company’s executive officers and such other employees of Lazard Ltd and its subsidiaries will also be eligible to directly or indirectly purchase or receive additional economic or other interests in the Company’s securities from Lazard Ltd and its subsidiaries, including additional Employee Participation Interests, on a discretionary basis in the future. The Sponsor and each of our executive officers and directors have agreed, subject limited exceptions, not transfer, assign sell Founder Shares until earliest year after completion Business Combination subsequent $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, least days date which liquidation, merger, share exchange other similar transaction that results Public Shareholders having the right exchange their Class ordinary shares cash, securities other property. IPO Promissory Note On Dec ember 17 2020, the Sponsor agreed to loan the Company an aggregate amount of up to $300,000 to be used to pay a portion of the expenses related to the Initial Public Offering, pursuant to unsecured revolving promissory note (the “IPO Promissory Note”). The IPO Promissory Note non-interest bearing payable earlier March 2021 (ii) the completion Initial Public Offering. December 31 2020, there was $86,750 outstanding under Promissory Note. On February 12, 2021, upon consummation of Related Party Loans In order finance transaction costs connection with Business Combination, the Sponsor committed $1,300,000 to be provided to the Company (“Working Capital Loan”) to fund our expenses relating to investigating and selecting a target business and other working capital requirements prior to our initial business combination. the Company completes Business Combination, the Company may repay the Working Capital Loan out the proceeds the Trust Account released the Company . In the event that Business Combination does not close, the Company may use portion of proceeds held outside the Trust Account to repay the Working Capital Loan, but no proceeds held the Trust Account would used repay the Working Capital Loan. At the lender’s discretion, up to $2,000,000 such Working Capital convertible of the post-Business Combination entity per . The warrants would be identical to the Private Placement Warrants. December 31 2020, Company outstanding borrowings, respectively, under the Loan. In addition, the Sponsor or an affiliate of the Sponsor may, but are not to, the Company additional may he terms oans, any, not agreements exist with Advisory Services Lazard Frères & Co. LLC, an affiliate of the Company, is acting as the Company’s independent financial advisor as defined under Financial Industry Regulatory Authority (“FINRA”) Rule 5110(j)(9), to provide independent financial consulting services, consisting of a review of deal structure and terms and related structuring advice in connection with the Initial Public Offering, for which it has and will receive a financial advisory fee, which was paid upon the closing of the Initial Public Offering and shall be payable upon the consummation of the Business Combination. Upon completion of the Initial Public Offering, Lazard Frères & Co. LLC received a financial advisory fee of $3,000,000. Pursuant to the terms of the underwriting agreement, the underwriter agreed to reimburse the Company for a portion of the offering costs in an amount equal to the fee to be paid to Lazard Frères & Co. LLC. On February 12, 2021, the underwriter reimbursed the Company $3,000,000. Administrative Support Agreement The Company agreed, commencing date that Company’s securities first listed the Nasdaq Capital Market, which was February 10, 2021, and through the earlier the Company’s consummation Business Combination liquidation, affiliate Sponsor total $20,000 month office space, secretarial and administrative support

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 6 - Fair Value Measurements Fair Value Hierarchy of Assets and Liabilities —The Company categorizes its warrants exercisable for Class A ordinary shares, which are recorded at fair value into a three-level fair value hierarchy as follows: Level 1. Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access. Level 2. Assets and liabilities whose values are based on (i) quoted prices for similar assets or liabilities in an active market, or quoted prices for identical or similar assets or liabilities in non-active markets, or (ii) inputs other than quoted prices that are directly observable or derived principally from, or corroborated by, market data. Level 3. Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect our own assumptions about the assumptions a market participant would use in pricing the asset or liability The Company’s Public Warrants exercisable for Class A ordinary shares began trading on Nasdaq in April 2021 at which time they were reclassified from Level 3 to Level 1. Their fair value at December 31, 2021 is based on an observable market quote. The fair value of the Public Warrants prior to the commencement of trading and the fair value of the Private Warrants is based on a valuation The following table presents, as of December 31, 2021, the classification of assets and liabilities measured at fair value on a recurring basis within the fair value hierarchy. December 31, 2021 Level 1 Level 2 Level 3 NAV Total Assets: Cash Equivalents Held in Trust Account $ 575,033,252 $ - $ - $ - $ 575,033,252 Total $ 575,033,252 $ - $ - $ - $ 575,033,252 Liabilities: Warrants exercisable for Class A ordinary shares $ 10,005,000 $ - $ 8,010,000 $ - $ 18,015,000 Total $ 10,005,000 $ - $ 8,010,000 $ - $ 18,015,000 The following tables provide a summary of the changes in fair value of the Company’s Level 3 liabilities for the year ended December 31, 2021. Year ended December 31, 2021 Beginning Balance Initial Fair Value Changes in Fair Value of Warrant Liabilities Transfers Ending Balance Liabilities: Public Warrants exercisable for Class A ordinary shares $ - $ 12,650,000 $ (1,150,000 ) $ (11,500,000 ) $ - Private Warrants exercisable for Class A ordinary shares - 9,900,000 (1,890,000 ) - 8,010,000 Total Level 3 Liabilities $ - $ 22,550,000 $ (3,040,000 ) $ (11,500,000 ) $ 8,010,000

Derivatives

Derivatives	12 Months Ended
Derivatives	Dec. 31, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivatives	Note 7 - Derivatives The Company’s The following table provides a summary of the changes in fair value of the Company’s derivative instruments for the year ended December 31, 2021. Warrants Exercisable for Class A Ordinary Shares Public Private Total Balance January 1, 2021 $ - $ - $ - Initial Fair Value as of February 12, 2021 12,650,000 9,900,000 22,550,000 Change in fair value as of December 31, 2021 (2,645,000 ) (1,890,000 ) (4,535,000 ) Balance as of December 31, 2021 $ 10,005,000 $ 8,010,000 $ 18,015,000

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 8 - Commitments and Contingencies Registration The holders Founder Shares, Private Placement Warrants warrants that issued upon conversion Working Capital Loan (and Class ordinary shares issuable upon exercise the Private Placement Warrants and the warrants that may be issued upon conversion of the Working Capital Loan) are entitled registration rights pursuant registration shareholder rights agreement signed on February 9, 2021. holders these securities entitled make three demands, excluding short form demands, that Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect registration statements filed subsequent completion Business Combination. However, registration shareholder rights agreement provides that Company is not required to cause registration statement filed under Securities become effective until termination applicable lockup period, which occurs (i) in the case of the Founder Shares, as described under the heading “Founders Shares” in Note 5, and (ii) in the case of the private placement warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of a Business Combination. registration rights agreement does not contain liquidating damages other cash settlement provisions resulting from delays registering securities. will bear with filing any such registration statements. Underwriting Agreement The Company granted the underwriter a 45-day option to purchase up to 7,500,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The underwriter exercised this over-allotment option in full on February 10, 2021. The underwriter is entitled to a cash underwriting discount of $0.20 per Unit, or $11,500,000 in the aggregate, which became payable upon the closing of the Initial Public Offering. In addition, the underwriter is entitled to a deferred commissions of $0.35 per Unit, or $20,125,000 in the aggregate. The deferred become payable underwriter’s from the amounts held the Trust Account solely the event that the Company completes Business Combination within the time required, subject the terms the underwriting agreement.

Shareholders' Equity

Shareholders' Equity	12 Months Ended
Shareholders' Equity	Dec. 31, 2021
Equity [Abstract]
Shareholders' Equity	Note 9 - Shareholders’ Equity Preference Shares The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences may determined from time time Company’s board directors. December 31 2021 and 2020, there were preference shares issued or outstanding. Class A Ordinary Shares The Company is authorized to issue 500,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At December 31, 2021 and 2020, there were 57,500,000 and 0 Class A ordinary shares issued or outstanding, respectively. Class B Ordinary Shares The Company is authorized to issue 50,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At December 31, 2021 and 2020, there were 14,375,000 Class B ordinary shares issued and outstanding. On February 10, 2021, in connection with the underwriter’s exercise of the over-allotment option in full, 1,875,000 Class B ordinary shares are no longer subject to forfeiture. Only holders of the the the to the and vote all law and (ii) with respect to the election of directors. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion Initial Public Offering, plus (ii) total number Class ordinary shares issued deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, the Company connection with relation the consummation Business Combination, excluding Class ordinary shares equity-linked securities exercisable for convertible into Class ordinary shares issued, deemed issued, or to be issued, to any seller in Business Combination and any Private Placement Warrants issued Sponsor, affiliates member Company’s management team upon conversion Working Capital Loan. event will the Class ordinary shares convert into Class ordinary shares rate of less than one-to-one. Warrants Exercisable for Class A Ordinary Shares Public Warrants may only be exercised for a whole number of shares. No fractional shares will be (i) days after completion Business Combination year from closing Initial Public Offering or liquidation. The Company is not obligated deliver Class ordinary shares pursuant exercise warrant has obligation settle such warrant exercise unless registration statement under the Securities with respect Class ordinary shares underlying warrants then effective prospectus relating thereto current, subject the Company satisfying its obligations with respect to the Company will obligated issue Class ordinary share upon exercise warrant unless Class ordinary share issuable upon such warrant exercise been registered, qualified deemed exempt under securities laws state residence registered holder warrants. The Company agreed as as practicable, in no event later 20 business days after the closing Business Combination, will commercially reasonable efforts file with for the the the issuable the and the use its the the and to maintain effectiveness of registration statement current prospectus relating to those Class the are the provided that Class time exercise not listed national the of Securities Act, Company may, option, require holders Public Warrants exercise the Act the event Company elects, Company not maintain effect registration but the use its the shares applicable sky laws extent exemption not available. statement the the not the day after closing Business Combination, may, time there effective and any the Company effective the Securities another exemption, Company will commercially reasonable efforts the sky the not available. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjus ted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. If and when warrants become redeemable Company, Company exercise redemption right even unable register qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A ordinary share equals or exceeds $ 10.00 . Once the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares; and • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted) on the trading day prior to the date the Company sends the notice of redemption to the warrant holders. If the Company calls Public Warrants for redemption, described above, management will have the option to require any holder that wishes to exercise the Public Warrants to do so on “cashless basis” . The exercise price and number ordinary shares issuable upon exercise the Public Warrants may adjusted certain circumstances including the event share dividend, extraordinary dividend recapitalization, reorganization, merger consolidation. However, except as described below, the Public Warrants will not adjusted for issuances ordinary shares price below exercise price. Additionally, event will Company required net cash settle Public Warrants. Company unable complete Business Combination within Combination Period and the Company liquidates the funds held the Trust Account, holders Public Warrants will not receive any such funds with respect their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect such Public Warrants. Accordingly, the Public Warrants expire worthless. In addition, (i) Company issues additional Class ordinary shares equity-linked securities for capital raising purposes connection with the closing of Business Combination issue price or effective issue price less than $9.20 per Class ordinary share (with such issue price effective issue price determined good faith the Company’s board directors and, the case any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor such affiliates, applicable, prior such issuance) (the “Newly Issued Price”), (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding Business Combination the date the consummation Business Combination (net redemptions), (iii) volume weighted average trading price Class ordinary shares during the 20 trading day period starting on the trading day prior the day on which the Company consummates Business Combination (such price, “Market Value”) below $9.20 share, exercise price warrants will adjusted (to nearest cent) equal 115 higher of Market Value Newly Issued Price, $18.00 share redemption trigger price will be adjusted (to the nearest cent) equal 180 the higher the Market Value and the Newly Issued Price, $10.00 per share redemption trigger price will adjusted (to nearest cent) equal to higher Market Value Newly Issued Price. The Private Placement Warrants will identical Public Warrants underlying Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class ordinary shares issuable upon the exercise the Private Placement Warrants will not transferable, assignable salable until days after completion Business Combination, subject certain limited exceptions. Additionally, Private Placement Warrants will exercisable cashless basis non-redeemable, except described above, long they are held the Sponsor its permitted transferees. If the Private Placement Warrants are held someone other than the initial purchasers their permitted transferees, Private Placement Warrants will redeemable Company exercisable such holders on the same basis the Public Warrants.

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 10 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events that would have required adjustment disclosure the financial statements. On March 30, 2022, the Sponsor further amended the Working Capital Loan to provide additional borrowing up to a total borrowing of $5,000,000.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared accordance with accounting principles generally accepted United States America (“GAAP”) pursuant rules regulations of
Emerging Growth Company	Emerging Growth Company The Company “emerging growth company,” defined Section 2(a) Securities Act, modified the Jumpstart Our Business Startups Act 2012 (the “JOBS Act”), and may take advantage certain exemptions from various reporting requirements that are applicable other public companies that are not emerging growth companies including, but not limited to, not being required comply with the auditor attestation requirements Section 404 the Sarbanes-Oxley Act 2002, reduced disclosure obligations regarding executive compensation its periodic reports and proxy statements, and exemptions Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies to comply with new revised financial accounting standards until private companies (that those that have not had Securities Act registration statement declared effective not have class securities registered under Exchange Act) required comply with revised financial accounting standards. The JOBS Act provides that company can elect opt out the extended transition period and comply with requirements that apply non-emerging growth companies but such election opt out irrevocable. Company elected not opt out such extended transition period which means that when standard issued revised different application dates public private companies, Company, emerging growth company, adopt revised standard time private companies adopt revised standard. This make comparison Company’s financial statements with another public company which neither emerging growth company emerging growth company which has opted out using extended transition period difficult impossible because the potential differences accounting standards used.
Use of Estimates	Use of Estimates The preparation financial statements conformity with GAAP requires management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Estimates, by their nature, are based o
Cash and Cash Equivalents Held in Trust Account	Cash and Cash Equivalents Held in Trust Account Cash and cash equivalents include cash on hand and on deposit at banking institutions as well as all highly liquid short-term investments with original maturities of ninety (90) days or less. The Company held cash of $660,069 and $25,000 in a demand deposit account as of December 31, 2021 and December 31, 2020, respectively. The Company held $575,033,252 and $0 as of December 31, 2021 and December 31, 2020, respectively, in the Trust Account that are characterized as Level I investments within the fair value hierarchy under ASC 820. The cash equivalents held in the Trust Account are held in money market funds and are considered restricted.
Deferred Offering Costs	Deferred Offering Costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. These costs, together with the upfront underwriting discounts, the deferred underwriting commissions and the financial advisory fee in connection with the Initial Public Offering were allocated between the Public Shares and Public Warrants and charged to shareholder’s equity and operating expenses, respectively, upon the completion of the Initial Public Offering.
Warrants Exercisable for Class A Ordinary Shares	Warrants Exercisable for Class A Ordinary Shares The Company accounts for the warrants issued in connection with the Initial Public Offering in accordance with ASC 480-10, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity,” which provides that the Company classifies the warrant instruments as a liability at its fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, in accordance with ASC Topic 815, and any change in fair value is recognized in the Company’s statement of operations.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, "Income Taxes" ("ASC 740"). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC Topic prescribes recognition threshold measurement attribute financial statement recognition measurement positions taken expected taken return. those benefits recognized, position must more likely than sustained upon examination taxing tax jurisdiction. Company recognizes accrued interest penalties related unrecognized benefits as amounts accrued interest penalties. Company currently aware issues under review that could result significant payments, deviation from position. The Company considered exempted Cayman Islands company with connection other the Cayman Islands United States. such, Company’s provision zero periods presented.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share Net loss per share is computed by dividing by weighted average number of ordinary shares outstanding during period, excluding ordinary shares subject to forfeiture As of December 31, 2020, the Company had 1,875,000 were to extent shares were excluded from the calculation of the basic and diluted w eighted average number of non-redeemable Class B shares outstanding and basic and diluted net loss per share of non-redee mable Class B ordinary shares. At December 31 , 2021 and 2020, the Company did no t have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the losses of the Company. As a result, diluted loss per share is the same as basic loss per share for the period s presented.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that $250,000. The Company not experienced losses this account and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value Company’s assets liabilities, which qualify financial instruments under ASC 820, “Fair Value Measurement,” approximates carrying amounts represented accompanying balance sheet, primarily due their short-term nature.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the Financial Accounting Standards Board issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for small reporting companies beginning January 1, 2024 and should be applied on a full or modified retrospective basis. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents, as of December 31, 2021, the classification of assets and liabilities measured at fair value on a recurring basis within the fair value hierarchy. December 31, 2021 Level 1 Level 2 Level 3 NAV Total Assets: Cash Equivalents Held in Trust Account $ 575,033,252 $ - $ - $ - $ 575,033,252 Total $ 575,033,252 $ - $ - $ - $ 575,033,252 Liabilities: Warrants exercisable for Class A ordinary shares $ 10,005,000 $ - $ 8,010,000 $ - $ 18,015,000 Total $ 10,005,000 $ - $ 8,010,000 $ - $ 18,015,000
Summary of Changes in Fair Value of Level 3 Liabilities	The following tables provide a summary of the changes in fair value of the Company’s Level 3 liabilities for the year ended December 31, 2021. Year ended December 31, 2021 Beginning Balance Initial Fair Value Changes in Fair Value of Warrant Liabilities Transfers Ending Balance Liabilities: Public Warrants exercisable for Class A ordinary shares $ - $ 12,650,000 $ (1,150,000 ) $ (11,500,000 ) $ - Private Warrants exercisable for Class A ordinary shares - 9,900,000 (1,890,000 ) - 8,010,000 Total Level 3 Liabilities $ - $ 22,550,000 $ (3,040,000 ) $ (11,500,000 ) $ 8,010,000

Derivatives (Tables)

Derivatives (Tables)	12 Months Ended
Derivatives (Tables)	Dec. 31, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Summary of Changes in Fair Value of Derivative Instruments	The following table provides a summary of the changes in fair value of the Company’s derivative instruments for the year ended December 31, 2021. Warrants Exercisable for Class A Ordinary Shares Public Private Total Balance January 1, 2021 $ - $ - $ - Initial Fair Value as of February 12, 2021 12,650,000 9,900,000 22,550,000 Change in fair value as of December 31, 2021 (2,645,000 ) (1,890,000 ) (4,535,000 ) Balance as of December 31, 2021 $ 10,005,000 $ 8,010,000 $ 18,015,000

Organization and Plan of Busi_2

Organization and Plan of Business Operations - Additional Information (Details) - USD ($)	Feb. 12, 2021	Feb. 10, 2021	Dec. 31, 2021	Mar. 30, 2022	Aug. 05, 2021	Mar. 26, 2021	Dec. 31, 2020
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Date of incorporation			Dec. 10, 2020
Restriction from redeeming of public shares without prior written consent in percentage			15.00%
Period for business combination to consummate after initial public offering			24 months
Sponsor commitment						$ 1,300,000
Cash			$ 660,069				$ 25,000
Proceeds from related party loans			2,000,000
Subsequent Event
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Available additional maximum borrowing capacity under sponsor amended working capital loans.				$ 5,000,000
Related Party Loans
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Available additional maximum borrowing capacity under sponsor amended working capital loans.					$ 2,000,000
Proceeds from related party loans			$ 2,000,000
Related Party Loans \| Subsequent Event
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Available additional maximum borrowing capacity under sponsor amended working capital loans.				$ 5,000,000
Business Combination
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Business combination per public share			$ 10
Minimum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Percentage of net assets held in trust account			80.00%
Condition for completing business combination applies if post-business combination company owns or acquires certain percentage			50.00%
Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Net tangible assets			$ 5,000,001
Interest payable for dissolution expenses			$ 100,000
Class A Ordinary Shares
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Percentage redemption of ordinary share in connection with initial business combination			100.00%
Class A Ordinary Shares \| Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Sale of stock, price per share			$ 12
Initial Public Offering \| Class A Ordinary Shares
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Issuance of ordinary shares, shares	57,500,000
Sale of stock, price per share	$ 10
Over-Allotment Option
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Issuance of ordinary shares, shares		7,500,000
Sale of warrants issued during period shares new issues	1,000,000
Over-Allotment Option \| Class A Ordinary Shares
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Issuance of ordinary shares, shares	7,500,000
Private Placement Warrants
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Sale of stock, price per share	$ 1.50
Sale of warrants issued during period shares new issues	9,000,000

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Details) - USD ($)	Feb. 10, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Significant Accounting Policies [Line Items]
Demand deposit account		$ 25,000	$ 660,069	$ 25,000
Cash equivalents held in Trust Account		0	575,033,252	0
Unrecognized tax benefits		0	0	0
Unrecognized tax benefit amounts accrued for interest and penalties		$ 0	0	0
Tax provision			0	0
Dilutive securities			0	$ 0
Federal depository insurance coverage			$ 250,000
Maximum
Significant Accounting Policies [Line Items]
Warrants outstanding			20,500,000
Over-Allotment Option
Significant Accounting Policies [Line Items]
Issuance of ordinary shares, shares	7,500,000
Class B Ordinary Shares \| Over-Allotment Option
Significant Accounting Policies [Line Items]
Issuance of ordinary shares, shares	1,875,000	1,875,000	1,875,000

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Details) - USD ($)	Feb. 12, 2021	Feb. 10, 2021	Dec. 31, 2021
Initial Public Offering [Line Items]
Public warrant, description			Each Unit consists of one Class A ordinary share and one-fifth of one redeemable warrant (“Public Warrant”).
Exercise price, per share			$ 1.50
Transaction costs	$ 32,476,988
Underwriting fees	11,500,000
Deferred underwriting fees	20,125,000		$ 20,125,000
Other offering costs	851,988
Lazard Frères & Co. LLC
Initial Public Offering [Line Items]
Financial advisory fee paid	$ 3,000,000
Class A Ordinary Shares
Initial Public Offering [Line Items]
Exercise price, per share	$ 11.50
Initial Public Offering \| Class A Ordinary Shares
Initial Public Offering [Line Items]
Issuance of ordinary shares, shares	57,500,000
Sale of stock, price per share	$ 10
Underwriter's Over-Allotment Option
Initial Public Offering [Line Items]
Issuance of ordinary shares, shares		7,500,000
Underwriting fees			11,500,000
Deferred underwriting fees			$ 20,125,000
Underwriter's Over-Allotment Option \| Class A Ordinary Shares
Initial Public Offering [Line Items]
Issuance of ordinary shares, shares	7,500,000

Private Placement - Additional

Private Placement - Additional Information (Details) - USD ($)	Feb. 12, 2021	Dec. 31, 2021
Private Placement [Line Items]
Exercise price, per share		$ 1.50
Adjustment in additional paid in capital for proceeds in excess of fair value of warrants issued	$ 3,600,000	$ 3,600,000
Private Placement Warrants
Private Placement [Line Items]
Fair value of warrants	$ 9,900,000
Private Placement Warrants
Private Placement [Line Items]
Sale of warrants issued during period shares new issues	9,000,000
Sale of stock, price per share	$ 1.50
Sale of warrants issued during period value new issues	$ 13,500,000
Proceeds from warrants issued	$ 13,500,000
Class A Ordinary Shares
Private Placement [Line Items]
Exercise price, per share	$ 11.50

Related Party Transactions - Fo

Related Party Transactions - Founder Shares - Additional Information (Details)	May 11, 2021shares	Feb. 05, 2021USD ($)Director$ / sharesshares	Dec. 17, 2020USD ($)shares	Dec. 31, 2021$ / sharesshares	Dec. 31, 2020shares
Class B Ordinary Shares
Related Party Transaction [Line Items]
Common stock, shares issued				14,375,000	14,375,000
Class A Ordinary Shares
Related Party Transaction [Line Items]
Common stock, shares issued				57,500,000	0
Class A Ordinary Shares \| Maximum
Related Party Transaction [Line Items]
Sale of stock, price per share \| $ / shares				$ 12
Founder Shares
Related Party Transaction [Line Items]
Related party transaction sponsor paid to purchase ordinary share \| $			$ 25,000
Founder shares as percentage of issued and outstanding ordinary shares after initial public offering			20.00%
Related party transaction sponsor transferred founder share to each independent directors		25,000
Number of independent directors \| Director		5
Related party transaction sponsor transferred founder share to independent directors		125,000
Related party transaction directors transferred back founder share previously received from sponsor.	25,000
Related party transaction sponsor transferred founder share to directors		100,000
Related party transaction fair value of sponsor transferred founder share to independent directors. \| $		$ 342,000
Related party transaction directors transferred back founder share previously received from sponsor. \| $ / shares		$ 3.42
Percentage of economic interests in founder shares		30.00%
Founder Shares \| Officer
Related Party Transaction [Line Items]
Percentage of economic interests in founder shares		2.00%
Founder Shares \| Maximum
Related Party Transaction [Line Items]
Related party transaction number of shares agreed by sponsor to forfeit founder shares			1,875,000
Founder Shares \| Class B Ordinary Shares
Related Party Transaction [Line Items]
Common stock, shares issued			14,375,000

Related Party Transactions - IP

Related Party Transactions - IPO Promissory Note - Additional Information (Details) - USD ($)	Feb. 12, 2021	Dec. 17, 2020	Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Borrowings outstanding repaid			$ 187,582
IPO Promissory Note
Related Party Transaction [Line Items]
Aggregate loan amount		$ 300,000
Maturity date		Mar. 31, 2021
Borrowings outstanding repaid	$ 187,583
Borrowings outstanding amount				$ 86,750

Related Party Transactions - Re

Related Party Transactions - Related Party Loans - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 30, 2022	Aug. 05, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Exercise price, per share	$ 1.50
Outstanding borrowings	$ 2,000,000			$ 0
Subsequent Event
Related Party Transaction [Line Items]
Aggregate loan amount		$ 5,000,000
Related Party Loans
Related Party Transaction [Line Items]
Loans	1,300,000
Aggregate loan amount			$ 2,000,000
Proceeds held in trust account	0
Related Party Loans \| Maximum
Related Party Transaction [Line Items]
Working capital loan to be convertible into warrants	$ 2,000,000
Related Party Loans \| Subsequent Event
Related Party Transaction [Line Items]
Aggregate loan amount		$ 5,000,000

Related Party Transactions - Ad

Related Party Transactions - Advisory Services - Additional Information (Details)	Feb. 12, 2021USD ($)
Related Party Transaction [Line Items]
Underwriter reimbursement as offering costs	$ 3,000,000
Lazard Frères & Co. LLC
Related Party Transaction [Line Items]
Financial advisory fee received	$ 3,000,000

Related Party Transactions - _2

Related Party Transactions - Administrative Support Agreement - Additional Information (Details)	Feb. 10, 2021USD ($)
Related Party Transactions [Abstract]
Office space, secretarial and administrative support expenses per month	$ 20,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Assets:
Cash equivalents held in Trust Account	$ 575,033,252	$ 0
Fair Value Measurements Recurring
Assets:
Cash equivalents held in Trust Account	575,033,252
Total	575,033,252
Liabilities:
Liabilities	18,015,000
Fair Value Measurements Recurring \| Level 1
Assets:
Cash equivalents held in Trust Account	575,033,252
Total	575,033,252
Liabilities:
Liabilities	10,005,000
Fair Value Measurements Recurring \| Level 3
Liabilities:
Liabilities	8,010,000
Fair Value Measurements Recurring \| Warrants Exercisable for Class A Ordinary Shares
Liabilities:
Liabilities	18,015,000
Fair Value Measurements Recurring \| Warrants Exercisable for Class A Ordinary Shares \| Level 1
Liabilities:
Liabilities	10,005,000
Fair Value Measurements Recurring \| Warrants Exercisable for Class A Ordinary Shares \| Level 3
Liabilities:
Liabilities	$ 8,010,000

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Changes in Fair Value of Level 3 Liabilities (Details) - Level 3	12 Months Ended
	Dec. 31, 2021USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Initial Fair Value	$ 22,550,000
Changes in Fair Value of Warrant Liabilities	(3,040,000)
Transfers	(11,500,000)
Ending Balance	8,010,000
Public Warrants Exercisable for Class A Ordinary Shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Initial Fair Value	12,650,000
Changes in Fair Value of Warrant Liabilities	(1,150,000)
Transfers	(11,500,000)
Private Warrants Exercisable for Class A Ordinary Shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Initial Fair Value	9,900,000
Changes in Fair Value of Warrant Liabilities	(1,890,000)
Ending Balance	$ 8,010,000

Derivatives - Summary of Change

Derivatives - Summary of Changes in Fair Value of Derivative Instruments (Details)	12 Months Ended
	Dec. 31, 2021USD ($)
Derivative [Line Items]
Change in fair value	$ (4,535,000)
Class A Ordinary Shares
Derivative [Line Items]
Initial Fair Value as of February 12, 2021	22,550,000
Change in fair value	(4,535,000)
Ending balance	18,015,000
Class A Ordinary Shares \| Public Warrants
Derivative [Line Items]
Initial Fair Value as of February 12, 2021	12,650,000
Change in fair value	(2,645,000)
Ending balance	10,005,000
Class A Ordinary Shares \| Private Placement Warrants
Derivative [Line Items]
Initial Fair Value as of February 12, 2021	9,900,000
Change in fair value	(1,890,000)
Ending balance	$ 8,010,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)	Feb. 12, 2021	Feb. 10, 2021	Dec. 31, 2021
Loss Contingencies [Line Items]
Payment of underwriting discount, amount	$ 11,500,000
Deferred underwriting commissions	$ 20,125,000		$ 20,125,000
Over-Allotment Option
Loss Contingencies [Line Items]
Number of days in option given to underwriter to purchase shares		45 days
Units issued in option		7,500,000
Payment of underwriting discount, per unit			$ 0.20
Payment of underwriting discount, amount			$ 11,500,000
Deferred underwriting commissions, per unit			$ 0.35
Deferred underwriting commissions			$ 20,125,000
Registration and Shareholders Rights Agreement
Loss Contingencies [Line Items]
Termination lockup period for warrants			30 days

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) - $ / shares	Feb. 12, 2021	Feb. 10, 2021	Dec. 31, 2020	Dec. 31, 2021
Class Of Stock [Line Items]
Preference shares, authorized			5,000,000	5,000,000
Preference shares, par value			$ 0.0001	$ 0.0001
Preference shares, issued			0	0
Preference shares, outstanding			0	0
Exercise price, per share				$ 1.50
Minimum percentage of total equity proceeds from issuances				60.00%
Percentage of exercise price of warrants adjusted equal to higher of market value and newly issued price				115.00%
Redemption triggering price of warrants				$ 18
Percentage of warrant redemption trigger price adjusted equal to higher of market value and newly issued price.				180.00%
Redemption trigger price adjusted equal to higher of market value and newly issued price.				$ 10
Public Warrants
Class Of Stock [Line Items]
Number of shares will be issued upon exercise of warrants				0
Warrants exercisable, description				The Public Warrants become exercisable on the later of (i) 30 days after the completion of a Business Combination and (ii) one year from the closing of the Initial Public Offering.
Warrants expiration term				5 years
Redemption of Warrants when Price per Class A Ordinary Share Equals or Exceeds $18.00
Class Of Stock [Line Items]
Redemption price				$ 18
Exercise price, per share				0.01
Redemption of Warrants when Price per Class A Ordinary Share Equals or Exceeds $10.00
Class Of Stock [Line Items]
Redemption price				10
Exercise price, per share				$ 0.10
Over-Allotment Option
Class Of Stock [Line Items]
Ordinary shares no longer subject to forfeiture		7,500,000
Class A Ordinary Shares
Class Of Stock [Line Items]
Ordinary shares, authorized			500,000,000	500,000,000
Ordinary shares, par value			$ 0.0001	$ 0.0001
Ordinary shares, voting rights				Holders of Class A ordinary shares are entitled to one vote for each share.
Ordinary shares issued			0	57,500,000
Ordinary shares outstanding			0	57,500,000
Exercise price, per share	$ 11.50
Maximum effective issue price to closing of business combination				$ 9.20
Number of trading days prior on consummates business combination				20 days
Maximum effective issue price to consummation of business combination				$ 9.20
Class A Ordinary Shares \| Over-Allotment Option
Class Of Stock [Line Items]
Ordinary shares no longer subject to forfeiture	7,500,000
Class B Ordinary Shares
Class Of Stock [Line Items]
Ordinary shares, authorized			50,000,000	50,000,000
Ordinary shares, par value			$ 0.0001	$ 0.0001
Ordinary shares, voting rights				Holders of the Class B ordinary shares are entitled to one vote for each share.
Ordinary shares issued			14,375,000	14,375,000
Ordinary shares outstanding			14,375,000	14,375,000
Ordinary shares, conversion basis				The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of the Working Capital Loan. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.
Class B Ordinary Shares \| Over-Allotment Option
Class Of Stock [Line Items]
Ordinary shares no longer subject to forfeiture		1,875,000	1,875,000	1,875,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Details)	Mar. 30, 2022USD ($)
Subsequent Event
Subsequent Event [Line Items]
Aggregate loan amount	$ 5,000,000